Akers Biosciences Share Discussion Threads

[wigwammer] 16/1/2017 10:38

"a constructive comment" (or at least something pertaining to knowledge of the company)Qaz - It was interesting to note in the last conference call that the breakeven level of sales had fallen from circa $7m to $4.6m pa, which implies cash burn has dropped from circa $80k pw to closer to $35k. This implies the newly raised cash may give them a 12-18 month window. Over that time it is possible they get traction on the wellness side - the market would, I suspect, richly reward even marginal success on this front, given a market cap of sub $10m.I'm disappointed management did not participate in the cash raise. It doesn't make a great deal of sense - even a token level of participation would have had an amplified impact on confidence. Perhaps they were limited for some reason or perhaps they intend purchasing in the after market. I think breath actuated tests are still a great idea - particularly when targeting a wellness market populated by health enthusiasts. With some medtechs the risk is getting the products to market - here, the risks are clearly related to trust. But nonetheless, if it works out from this valuation level and the risks are ameliorated, investors will be very well rewarded, imo dyor.

[wigwammer] 16/1/2017 10:23

Enjoy Transylvania.

[norbus] 14/1/2017 17:41

There is plenty of life in me; sadly you can't say the same about Walter's outfit. Just sucking money

[algernon2] 13/1/2017 21:57

Cheer up Norbus,there's life in you yet.

[norbus] 13/1/2017 13:41

Basket case

[qazwsxedc69] 13/1/2017 10:02

"These could half again in a week".

And you could make a constructive comment in a week. Strange things do sometimes happen.....

[norbus] 12/1/2017 06:38

Not silk purse from a sow's ear ; today is the deadline to close. I hope for all holders sake that the $1.20 pricing is from greed and not despair. These could half again in a week

[norbus] 11/1/2017 15:22

Duck or no dinner.

[norbus] 10/1/2017 09:16

something not right whichever way you look at it.
Someone stealing a chunk cheap,
or curtains being measured

[mcmather] 10/1/2017 09:01

The initial S3 form included the comment: "...and a per share price of $3.30 based on the closing sale price of our common stock on October 18, 2016". The price of $1.20 with warrants at $1.50 suggests to me either gross incompetence or, as you say Norbus, no confidence in the company and the management. Or perhaps both.

[norbus] 10/1/2017 07:45

$1.2 for $2000000 !

I doubt this is careful housekeeping and most likely the market had enough; Even money they will
not make it; I say that, because if revenues were on doorstep from China,they can underwrite them
and at much higher than $1.20; I also think this money is coming from insider back pockets.
I over rated the CEO on his past M&A record. I think he is past his sell by date

[norbus] 09/1/2017 07:42

mcm

Looking for the RNS I could not find on their website, I see so many people around the company; board management etc.. You'd think they are running a big company

[norbus] 04/1/2017 07:08

And again

I reckon they are seriously stuck for some real news before they put their hands out to siphon more money into the benefits pot. Critical Junction if China does not come through

[mcmather] 03/1/2017 20:28

Likewise algernon.

Still no new SEC filings for AKERs:

[algernon2] 31/12/2016 19:08

Happy New year to all Akers Biosciences Holders: May 2017 be Merry and Bright for us all.

[norbus] 22/12/2016 11:08

You are sick; CAP was a gamble; I win some, lose some. I win more than I lose you small minded foof.

[wigwammer] 22/12/2016 10:31

Oh sorry, I seem to have upset you.I can confirm no fraud was required to sink CAP. The business case did that. Did you enjoy waiting around for that finale too?

[wigwammer] 21/12/2016 13:22

In the event of a cash call it will be interesting to see if investors/management back the story here, or if those most in the know decide it is an utterly hopeless investment story (as they did, for example, with Clean Air Power).

[norbus] 21/12/2016 09:41

mcm

One can't do better than to listen to ramridge, a potential investor with no axe to grind like us oldies. AKR only owes me costs of a due diligence trip for 2 to NJ but otherwise a few bob profit on one small trade. I guess I am only here to see the finale when it comes. The survival now surely depends on China being real.

[wigwammer] 21/12/2016 07:54

They are running low on cash and will likely make a cash call soon. That explains the lack of price reaction.The breathalyser product was a dud - you didn't need to see it fail to know it would fail. But they are pushing different markets now, with different products and with a more experienced sales operation.Evidently there is a lot of scepticism. Great. If there had been a lot of competition to buy the shares I wouldn't be sitting on a sub £1 entry price.

[werewolfie] 20/12/2016 17:02

Not much of an increase today. But Akers has been all mouth and no trousers from the start